Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Cell Death & Disease|October 13, 2017
The level of caveolin-1 expression determines response to TGF-β as a tumour suppressor in hepatocellular carcinoma cellsJoaquim Moreno-Càceres, Daniel Caballero-Díaz, Zeribe Chike Nwosu, et al.
Cell Death & Disease|September 17, 2024
Iron chelation as a new therapeutic approach to prevent senescence and liver fibrosis progressionJosep Amengual, Ania Alay, Javier Vaquero, et al.
Journal of Cell Science|October 9, 2010
Snail1 suppresses TGF-beta-induced apoptosis and is sufficient to trigger EMT in hepatocytesD Lorena Franco, Jèssica Mainez, Sonia Vega, et al.
Molecular Oncology|July 9, 2024
PRRX1 silencing is required for metastatic outgrowth in melanoma and is an independent prognostic of reduced survival in patientsJosep R Ferreres, Antònia Vinyals, Rafael Campos-Martin, et al.
Cancer Letters|February 6, 2017
Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinomaAndrea Malfettone, Jitka Soukupova, Esther Bertran, et al.
Journal of Materials Science. Materials in Medicine|July 8, 2017
Hybrid polymeric-protein nano-carriers (HPPNC) for targeted delivery of TGFβ inhibitors to hepatocellular carcinoma cellsNemany A N Hanafy, Alessandra Quarta, Riccardo Di Corato, et al.
JHEP Reports : Innovation in Hepatology|April 9, 2026
The endonuclease MCPIP1 protects against liver cancer development in a sex-dependent manner by modulating β-catenin and CREB1Oliwia Kwapisz, Paulina Marona, Judyta Gorka, et al.
Scientific Reports|October 4, 2017
Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolismJitka Soukupova, Andrea Malfettone, Petra Hyroššová, et al.
Journal of Hepatology|September 29, 2019
Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancerDaniel Caballero-Díaz, Esther Bertran, Irene Peñuelas-Haro, et al.
International Journal of Cancer|July 24, 2014
A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cellsJoan Fernando, Andrea Malfettone, Edgar B Cepeda, et al.
Pageof 13